Per-Uno Malmstrom
Overview
Explore the profile of Per-Uno Malmstrom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
165
Citations
3475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Mezheyeuski A, Backman M, Mattsson J, Martin-Bernabe A, Larsson C, Hrynchyk I, et al.
EBioMedicine
. 2023 Feb;
88:104452.
PMID: 36724681
Background: Cancer immunity is based on the interaction of a multitude of cells in the spatial context of the tumour tissue. Clinically relevant immune signatures are therefore anticipated to fundamentally...
12.
Haggstrom C, Hagberg O, Gardmark T, Aljabery F, Strock V, Hosseini A, et al.
BMJ Open
. 2023 Jan;
12(12):e064898.
PMID: 36600418
Purpose: We constructed Bladder Cancer Data Base Sweden (BladderBaSe) 2.0 to expand studies in BladderBaSe on incidence, treatment outcomes, side effects, survival and health economic aspects of men and women...
13.
Holmberg L, Hagberg O, Haggstrom C, Gardmark T, Strock V, Aljabery F, et al.
PLoS One
. 2022 Sep;
17(9):e0274859.
PMID: 36149914
Background: Previous research has associated repeated transurethral procedures after a diagnosis of non-muscle invasive bladder cancer (NMIBC) with increased risk of death of causes other than bladder cancer. Aim: We...
14.
Furuya H, Sasaki Y, Chen R, Peres R, Hokutan K, Murakami K, et al.
Sci Rep
. 2022 Jul;
12(1):12186.
PMID: 35842542
The extracellular activity of Plasminogen activator inhibitor-1 (PAI-1) is well described, acting as an inhibitor of tissue plasminogen activator and urokinase-type plasminogen activator, impacting fibrinolysis. Recent studies have revealed a...
15.
Wang E, Pihlstrom N, Malmstrom P, Gardmark T
Scand J Urol
. 2022 May;
56(3):221-226.
PMID: 35575423
Objective: The most common form of urinary bladder cancer is the low and intermediate risk categories of stage Ta. This patient group has a high recurrence rate, but progression is...
16.
Meisl C, Karakiewicz P, Einarsson R, Koch S, Hallmann S, Weiss S, et al.
BJU Int
. 2021 Dec;
130(6):754-763.
PMID: 34928524
Objectives: To evaluate the clinical utility of the urinary bladder cancer antigen test UBC Rapid for the diagnosis of bladder cancer (BC) and to develop and validate nomograms to identify...
17.
18.
Kerzeli I, Lord M, Doroszko M, Elgendy R, Chourlia A, Stepanek I, et al.
PLoS One
. 2021 Jul;
16(7):e0253178.
PMID: 34232958
Bladder cancer, one of the most prevalent malignancies worldwide, remains hard to classify due to a staggering molecular complexity. Despite a plethora of diagnostic tools and therapies, it is hard...
19.
Liedberg F, Hagberg O, Aljabery F, Gardmark T, Hosseini A, Jahnson S, et al.
Scand J Urol
. 2021 Jun;
55(4):276-280.
PMID: 34124994
Objective: For patients undergoing radical cystectomy for bladder cancer, a procedure requiring complex urinary tract reconstruction prone to major postoperative complications, the timing and quality of the surgery have been...
20.
Andersson M, Berger M, Zieger K, Malmstrom P, Blackberg M
Scand J Urol
. 2021 May;
55(4):263-267.
PMID: 34037496
Purpose: To investigate whether outpatient blue-light flexible cystoscopy could solve the diagnostic challenge of positive or suspicious urine cytology findings despite normal white-light flexible cystoscopy results and normal findings on...